文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia.

作者信息

Ganjali Shiva, Keshavarz Reihaneh, Hosseini Susan, Mansouri Atena, Mannarino Massimo R, Pirro Matteo, Jamialahmadi Tannaz, Sahebkar Amirhossein

机构信息

Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.

Department of Genetics, Faculty of Biological Sciences, Tehran North Branch, Islamic Azad University, Tehran 1651153311, Iran.

出版信息

J Clin Med. 2021 Dec 14;10(24):5867. doi: 10.3390/jcm10245867.


DOI:10.3390/jcm10245867
PMID:34945165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8707741/
Abstract

BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterizied by elevated levels of circulating low-density lipoprotein cholesterol (LDL-C) which is an important source of substrates to be oxidized by different oxidative agents. Subsequently, the oxidized LDLs (oxLDLs) induce further oxidative reactions in FH patients, which contributes to the development of atherosclerosis and advanced cardiovascular events in these patients. This study aimed to investigate the association of oxidant/antioxidant markers with FH. METHODS: This case-control study comprised 18 HoFH, 18 HeFH, and 20 healthy subjects. Oxidant/antioxidant markers including MDA, MPO, thiol, nitric oxide (NO), myeloperoxidase (MPO), glutathione peroxidase (GPx), SOD, and CAT were assessed by colorimetric methods. Prooxidant-antioxidant balance was also measured by pro-oxidant antioxidant balance (PAB) assay. RESULTS: The levels of MDA ( < 0.001), MPO activity ( < 0.001), thiol ( < 0.001), NO ( < 0.01), and PAB ( < 0.001) were notably higher in HoFH group in comparison with healthy subjects. HeFH group also showed significantly higher levels of thiol ( < 0.001) and PAB ( < 0.001) when compared to healthy subjects. Elevated levels of MDA ( < 0.001) and PAB ( < 0.001) were also observed in HoFH relative to HeFH. No significant differences were found between the studied groups in the case of antioxidant enzyme activities. The results of binary logistic regression showed that PAB (OR: 0.979; = 0.033), and MDA (OR: 0.996; = 0.018) levels were inversely associated with HoFH, although, after adjustment for age and LDL-C levels, these associations were diminished. CONCLUSION: Several oxidant/antioxidant differences were found between FH patients and healthy individuals as well as between HoFH and HeFH patients. These differences might be strongly dependent on plasma LDL-C levels.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/14a7a6a9866c/jcm-10-05867-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/a499d37aacd0/jcm-10-05867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/e7488b026a62/jcm-10-05867-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/14a7a6a9866c/jcm-10-05867-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/a499d37aacd0/jcm-10-05867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/e7488b026a62/jcm-10-05867-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bebf/8707741/14a7a6a9866c/jcm-10-05867-g003.jpg

相似文献

[1]
Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia.

J Clin Med. 2021-12-14

[2]
Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.

J Clin Lipidol. 2016

[3]
Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy.

J Am Heart Assoc. 2013-4-24

[4]
Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.

J Clin Lipidol. 2014

[5]
Association between Oxidative Burden and Restenosis: A Case-Control Study.

Oxid Med Cell Longev. 2022

[6]
Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia.

J Clin Med. 2023-1-6

[7]
Homozygous Familial Hypercholesterolemia.

J Atheroscler Thromb. 2021-7-1

[8]
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.

J Am Coll Cardiol. 2020-2-18

[9]
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.

J Am Coll Cardiol. 2014-3-12

[10]
CTCA in children with severe heterozygous familial hypercholesterolaemia: Screening for subclinical atherosclerosis.

Atheroscler Plus. 2023-12-13

引用本文的文献

[1]
Hypercholesterolemia, oxidative stress, and low-grade inflammation: a potentially dangerous scenario to blood-brain barrier.

Metab Brain Dis. 2025-5-17

[2]
The Dual Role of Oxidative Stress in Atherosclerosis and Coronary Artery Disease: Pathological Mechanisms and Diagnostic Potential.

Antioxidants (Basel). 2025-2-26

[3]
Evaluation of miRNA-27a/b expression in patients with familial hypercholesterolemia.

Arch Med Sci. 2022-5-29

[4]
Profiling of differentially expressed MicroRNAs in familial hypercholesterolemia via direct hybridization.

Noncoding RNA Res. 2024-3-8

[5]
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia.

Sci Rep. 2024-1-31

[6]
iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.

Int J Mol Sci. 2024-1-5

[7]
Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions.

Int J Mol Sci. 2023-10-18

[8]
Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.

Mol Biol Rep. 2023-10

[9]
Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders.

Cells. 2023-5-8

[10]
Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia.

Metabolites. 2023-1-29

本文引用的文献

[1]
Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.

Trends Cardiovasc Med. 2021-5

[2]
Thiol/Disulfide Balance in Patients with Familial Hypercholesterolemia.

Cardiol Res Pract. 2018-6-12

[3]
Oxidative stress and cardiovascular disease: new insights.

Kardiol Pol. 2018-3-14

[4]
Oxidative burden in familial hypercholesterolemia.

J Cell Physiol. 2018-3-7

[5]
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions.

Prog Lipid Res. 2017-5-12

[6]
Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Lipids Health Dis. 2017-4-24

[7]
Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).

Circulation. 2016-3-15

[8]
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.

Eur Heart J. 2016-2-22

[9]
Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.

Can Fam Physician. 2016-1

[10]
Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart.

Oxid Med Cell Longev. 2016

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索